FDA Releases Another National Reminder For Treatment Against Hypertension – Health News

INDIANAPOLIS (WTHR) – The FDA is recalling more drugs for hypertension.

The drug continues to be Losartan, which has been implicated in several other recalls, but this time it's Macleods Pharmaceuticals Limited that broadcasts the recall.

The tablets, which are 100 mg / 25 mg, have been recalled due to an impurity that can cause cancer.

"The detected impurity is N-nitrosodiethylamine (NDEA), a naturally occurring substance in some foods, drinking water, air pollution and industrial processes. IARC), "according to the FDA.

The product information for the recall is as follows:

• NDC: 33342005210; Lot / lot: BLM715A; Expiration date: July 2019.

Any adverse reactions to the product should be reported to the FDA MedWatch Adverse Events Reporting Program. Consumers can call 1-800-332-1088.